<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./P-23_files/filelist.xml">
<link rel=Edit-Time-Data href="./P-23_files/editdata.mso">
<link rel=OLE-Object-Data href="./P-23_files/oledata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>PRACTICAL APPLICATION OF THERMAL IONIZATION MASS SPECTROMETRY ANALYSIS
OF PLUTONIUM FOR THE LANL BIOASSAY PROGRAM</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>lanl</o:Author>
  <o:LastAuthor>Mary Anne Lauby</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:LastPrinted>2000-04-06T17:29:00Z</o:LastPrinted>
  <o:Created>2000-09-28T18:27:00Z</o:Created>
  <o:LastSaved>2000-09-28T18:27:00Z</o:LastSaved>
  <o:Pages>11</o:Pages>
  <o:Words>3673</o:Words>
  <o:Characters>20939</o:Characters>
  <o:Company>lanl</o:Company>
  <o:Lines>174</o:Lines>
  <o:Paragraphs>41</o:Paragraphs>
  <o:CharactersWithSpaces>25714</o:CharactersWithSpaces>
  <o:Version>9.2720</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEvery>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:UseMarginsForDrawingGridOrigin/>
  <w:Compatibility>
   <w:FootnoteLayoutLikeWW8/>
   <w:ShapeLayoutLikeWW8/>
   <w:AlignTablesRowByRow/>
   <w:ForgetLastTabAlignment/>
   <w:LayoutRawTableWidth/>
   <w:LayoutTableRowsApart/>
  </w:Compatibility>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:HELVETICA;
	panose-1:2 11 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	line-height:200%;
	mso-pagination:none;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-font-kerning:0pt;
	layout-grid-mode:line;
	font-weight:normal;
	text-decoration:underline;
	text-underline:single;}
h2
	{mso-style-next:Normal;
	margin-top:0in;
	margin-right:4.5pt;
	margin-bottom:0in;
	margin-left:-.25in;
	margin-bottom:.0001pt;
	line-height:200%;
	mso-pagination:none;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	layout-grid-mode:line;
	font-weight:normal;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{margin-top:0in;
	margin-right:4.5pt;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-indent:-.25in;
	mso-pagination:none;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	layout-grid-mode:line;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{margin-top:0in;
	margin-right:4.5pt;
	margin-bottom:0in;
	margin-left:-.25in;
	margin-bottom:.0001pt;
	text-indent:.5in;
	line-height:200%;
	mso-pagination:none;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	layout-grid-mode:line;}
p.WP9, li.WP9, div.WP9
	{mso-style-name:WP9_;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:none;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-style:italic;
	mso-bidi-font-style:normal;}
p.HTMLBody, li.HTMLBody, div.HTMLBody
	{mso-style-name:"HTML Body";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:none;
	font-size:14.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.BodyTextI1, li.BodyTextI1, div.BodyTextI1
	{mso-style-name:"Body Text I1";
	margin:0in;
	margin-bottom:.0001pt;
	text-indent:.5in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.level3, li.level3, div.level3
	{mso-style-name:_level3;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	margin-bottom:.0001pt;
	text-indent:-.25in;
	mso-pagination:none;
	tab-stops:.75in .75in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
p.BodyTextIn, li.BodyTextIn, div.BodyTextIn
	{mso-style-name:"Body Text In";
	margin:0in;
	margin-bottom:.0001pt;
	text-indent:.5in;
	line-height:150%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
@page Section1
	{size:8.5in 11.0in;
	margin:58.5pt 1.0in 58.5pt 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-header:url("./P-23_files/header.htm") h1;
	mso-even-footer:url("./P-23_files/header.htm") ef1;
	mso-footer:url("./P-23_files/header.htm") f1;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
 /* List Definitions */
@list l0
	{mso-list-id:248344356;
	mso-list-type:simple;
	mso-list-template-ids:868410440;}
@list l0:level1
	{mso-level-start-at:2;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:-.25in;
	mso-ansi-font-style:normal;}
@list l1
	{mso-list-id:449861835;
	mso-list-type:simple;
	mso-list-template-ids:868410440;}
@list l1:level1
	{mso-level-start-at:4;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:-.25in;}
@list l2
	{mso-list-id:578489005;
	mso-list-type:simple;
	mso-list-template-ids:868410440;}
@list l2:level1
	{mso-level-tab-stop:0in;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:-.25in;}
@list l3
	{mso-list-id:644428821;
	mso-list-type:simple;
	mso-list-template-ids:-1927005840;}
@list l3:level1
	{mso-level-start-at:2;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:-.25in;}
@list l4
	{mso-list-id:790052925;
	mso-list-type:simple;
	mso-list-template-ids:868410440;}
@list l4:level1
	{mso-level-start-at:4;
	mso-level-tab-stop:0in;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:-.25in;}
@list l5
	{mso-list-id:1387485729;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l5:level1
	{mso-level-start-at:3;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l6
	{mso-list-id:1621230612;
	mso-list-type:simple;
	mso-list-template-ids:67698703;}
@list l6:level1
	{mso-level-start-at:3;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2050"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><!--[if supportFields]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><span
style='mso-element:field-begin'></span><span style="mso-spacerun:
yes"> </span>SEQ CHAPTER \h \r 1</span><![endif]--><!--[if supportFields]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><span
style='mso-element:field-end'></span></span><![endif]--><span style='font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Practical
Application of Thermal Ionization Mass Spectrometry for the Determination of
Plutonium for the LANL Bioassay Program<o:p></o:p></span></p>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><span
style="mso-spacerun: yes"> </span>(LA-UR-00-1697)<o:p></o:p></span></p>

<p class=HTMLBody style='mso-pagination:widow-orphan'><span style='font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Sandra
E. Wagner*, Stephanie Boone, John W. Chamberlin, Clarence J. Duffy, Deward W.
Efurd, Kimberley M. Israel, Nancy L. Koski, Diana L. Kottmann, Dawn Lewis, <o:p></o:p></span></p>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Peter
C. Lindahl, Fred R. Roensch, Robert E. Steiner<o:p></o:p></span></p>

<p class=HTMLBody style='mso-pagination:widow-orphan'><span style='font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody style='mso-pagination:widow-orphan'><span style='font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody align=center style='margin-right:-.5in;text-align:center;
mso-pagination:widow-orphan;mso-outline-level:1'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Los Alamos National
Laboratory, P.O. Box 1663, MS J514, Los Alamos, NM, USA<span
style="mso-spacerun: yes">  </span>87545<i style='mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Presented
at the Fifth International <o:p></o:p></span></p>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Conference
on Methods and Applications of Radioanalytical Chemistry (MARC V) <o:p></o:p></span></p>

<p class=HTMLBody align=center style='text-align:center;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Kailua-Kona,
HI, USA, April 9-14, 2000<o:p></o:p></span></p>

<p class=HTMLBody style='mso-pagination:widow-orphan'><span style='font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody style='mso-pagination:widow-orphan'><span style='font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody style='margin-top:0in;margin-right:.5in;margin-bottom:0in;
margin-left:22.5pt;margin-bottom:.0001pt;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>This
paper discusses the practical application of thermal ionization mass
spectrometry for the determination of ultra low-level plutonium in urine for
the Los Alamos National Laboratory Bioassay Program.<span style="mso-spacerun:
yes">  </span>Utilization of thermal ionization mass spectrometry as a routine
analytical service provided to the Los Alamos National Laboratory internal
dosimetry group has evolved significantly since its implementation just over
three years ago.<span style="mso-spacerun: yes">  </span>Converting this unique
research tool designed to support nuclear weapons testing to a quasi-production
mode for the routine analysis of ~300 urine samples/year has required resolution
of numerous practical issues. <span style="mso-spacerun: yes"> </span>These
issues include clean-room sample preparation, adequate tracer recovery,
customer specified turn-around times, throughput, water and urine blank values,
statistical data reduction, and quality control and performance evaluation
sample requirements.<span style="mso-spacerun: yes">  </span>Ongoing
improvements identified include software development and electronics upgrades
to allow automation of the system for reduced labor costs and increased
efficiency. <o:p></o:p></span></p>

<p class=HTMLBody style='margin-top:0in;margin-right:.75in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:.75in;mso-pagination:widow-orphan'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
font-family:"Times New Roman"'>INTRODUCTION <o:p></o:p></span></p>

<p class=HTMLBody style='text-indent:.5in;line-height:200%;mso-outline-level:
1'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Routine
bioassay monitoring for Department of Energy workers who may incur intakes of
radioactive materials resulting in a committed effective dose equivalent of 100
mrem (0.1 mSv) is mandated by United States law [1].<span style="mso-spacerun:
yes">  </span>To provide the level of measurement sensitivity necessary to meet
this monitoring requirement, Los Alamos National Laboratory (LANL) developed an
ultra-sensitive analytical procedure through the application of thermal
ionization mass spectrometry (TIMS) for determination of plutonium-239/240 in
urine samples [2].<o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan'><span style='font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"'>Since the days of the Manhattan
Engineering District Project, plutonium-worker monitoring was accomplished
through radiochemical alpha spectroscopy (RAS), which besides being less
sensitive, cannot distinguish between the isotopes of plutonium-239/240.<span
style="mso-spacerun: yes">  </span>However, RAS remains the technique for the
determination of plutonium-238 and -239 in routine monitoring, and TIMS is used
as an adjunct for baseline and front-line plutonium workers providing more
sensitive determinations of plutonium-239, and the 239/240 ratio.<o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan'><span style='font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"'>For over 40 years, TIMS was a well-established
research tool used for analysis of one-of-a-kind samples.<span
style="mso-spacerun: yes">  </span>Since the addition of the TIMS procedure to
the LANL Bioassay Program in January 1997, numerous technical and management
challenges have been encountered during the transition from a specialized
research tool to a production analytical technique.<span style="mso-spacerun:
yes">  </span>Chemical separation procedures used in the determination of RAS
levels of plutonium were not suitable for the more sensitive TIMS analyses.<span
style="mso-spacerun: yes">  </span>Numerous opportunities for quality
improvement have occurred in the three years of routine TIMS operations to
support the LANL Bioassay Program. These lessons could only be learned once
TIMS was implemented, as the first series of problems had to be solved before
the next set of challenges were identified.<o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><b style='mso-bidi-font-weight:normal'><span style='font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></b></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
font-family:"Times New Roman"'>PLUTONIUM PROCESS CHEMISTRY<o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan;mso-outline-level:1'><u><span style='font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"'>RAS Analysis</span></u><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'><o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan;mso-outline-level:1'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>All LANL Bioassay
Program samples are analyzed for plutonium by RAS first, and then if requested,
by TIMS.<span style="mso-spacerun: yes">  </span>The RAS portion of the process
starts with determination of sample parameters (temperature, weight, and specific
gravity).<span style="mso-spacerun: yes">  </span>Plutonium-242 tracer is added
to the sample prior to processing.<span style="mso-spacerun: yes">  
</span>Calcium nitrate, phosphoric acid and ammonium hydroxide are added to the
urine to precipitate the plutonium from solution.<span style="mso-spacerun:
yes">  </span>The sample is centrifuged, and the supernatant liquid is decanted
and discarded, leaving the precipitated plutonium solids.<span
style="mso-spacerun: yes">  </span>The solids are dissolved in nitric acid and
heated.<span style="mso-spacerun: yes">  </span>The solution is then
transferred into a Class-100 clean-room.<span style="mso-spacerun: yes"> 
</span>The nitric acid solution is passed through an anion exchange column, and
the plutonium is eluted from the column with hydrochloric acid followed by a
hydroiodic acid solution.<span style="mso-spacerun: yes">  </span>The solution
is evaporated to dryness.<span style="mso-spacerun: yes">  </span>The sample is
redissolved in a sodium bisulfate-sodium sulfate solution and electroplated
onto a stainless steel planchette.<span style="mso-spacerun: yes">  </span>The
planchette is alpha counted for plutonium-238 and-239.<span
style="mso-spacerun: yes">  </span><o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><u><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
font-family:"Times New Roman"'>TIMS Chemistry<o:p></o:p></span></u></p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan;mso-outline-level:1'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>All chemistry done to
support the preparation of the TIMS samples is conducted in a Class-100
clean-room environment. The stainless steel planchette from alpha-spectroscopy
analysis is washed with a hydrofluoric/nitric acid solution to remove the
plutonium. The plutonium solution is passed through an anion exchange column
and the plutonium is eluted from the column with a hydrochloric/hydroiodic acid
solution. The sample is evaporated to dryness and re-dissolved in a
hydrochloric acid/hydrogen peroxide solution. The sample is loaded onto a
second anion exchange column and the plutonium is eluted with hydrobromic
acid.<span style="mso-spacerun: yes">  </span>The plutonium solution is
evaporated to dryness in a pre-cleaned quartz test tube. <o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><u><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
font-family:"Times New Roman"'>TIMS Analysis <o:p></o:p></span></u></p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan;mso-outline-level:1'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>The solid material is
dissolved in a buffered hydrochloric acid-ammonium hydroxide solution.<span
style="mso-spacerun: yes">  </span>The plutonium is co-electroplated with
platinum onto a rhenium filament.<span style="mso-spacerun: yes">  </span>The
platinum-plutonium layer is overplated with platinum.<span style="mso-spacerun:
yes">  </span>The filament is inserted into the ion source of the mass
spectrometer, and a current is passed through the filament causing the
plutonium atoms to ionize. The ions are accelerated through a magnetic field,
resulting in separation of the ions by mass, with heavier ions having more
momentum.<span style="mso-spacerun: yes">   </span>The amount of plutonium-239
in the original sample is calculated by comparing the number of those ions to
ions resulting from a known amount of plutonium-242 tracer. TIMS analytical
operations are conducted in a Class-100 clean-room environment.<o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
font-family:"Times New Roman"'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><b style='mso-bidi-font-weight:normal'><span style='font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>CONTRACTUAL
PERFORMANCE REQUIREMENTS</span></b><span style='font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"'> <o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan;mso-outline-level:1;tab-stops:list .25in'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>During
the three years of TIMS implementation, the data generators and the end-user of
the data—the LANL Dosimetry Program—have developed and refined specific technical,
performance, cost and quality data requirements.<span style="mso-spacerun:
yes">  </span>All LANL bioassay analytical work is done in accordance with a
detailed Project Management Plan that includes an Analytical Service Agreement,
Data Acceptance Criteria, Quality Assurance Project Plan, and detailed
analytical procedures [3].<span style="mso-spacerun: yes">  </span>These
documents contain the specific requirements for the products and services to be
provided to ensure that quality assured and sufficient data are reported to the
end-user.<span style="mso-spacerun: yes">  </span>The LANL Analytical Bioassay
Program is also conducted in compliance with the requirements of the DOE
Laboratory Accreditation Program (DOELAP) [4].<o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><u><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
font-family:"Times New Roman"'>Internal tracer recovery<o:p></o:p></span></u></p>

<p class=BodyTextI1 style='margin-right:4.5pt;line-height:200%;mso-outline-level:
1'>Tracer recovery in radiochemical analysis methods is an important factor in
achieving lower detection levels for the determination of plutonium. A
plutonium-242 spike is added as an internal tracer to each urine sample, blank
and quality control (QC) sample. Tracer recoveries, as established by the
end-user of the data and determined by RAS, must fall between 40% and 110 % for
RAS, and between 15% and 110% for TIMS.<span style="mso-spacerun: yes"> 
</span>The percent tracer recovery results are tracked on a monthly basis as
part of the overall bioassay quality assurance (QA) program.<span
style="mso-spacerun: yes">  </span>Samples that do not meet the tracer recovery
requirements are re-collected from the individual being monitored, and
re-analyzed (re-runs).</p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan'><span style='font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"'>The tracer recovery performance has
improved dramatically over the past three years.<span style="mso-spacerun:
yes">   </span>In the first year of production TIMS analysis, the number of
re-runs was not tracked or evaluated.<span style="mso-spacerun: yes"> 
</span>However, complaints from individuals being monitored indicated that
numerous requests for resubmission of samples were occurring.<span
style="mso-spacerun: yes">   </span>In CY1998, re-runs were carefully tracked,
and reached an all-time high of 30% when a work-suspension was enacted on the
RAS portion of the plutonium bioassay program. The corrective actions resulting
from the work-suspension included a technician certification program that
required a dedicated technician for complete analysis of a sample set, allowing
personal accountability for the quality of each sample set.<span
style="mso-spacerun: yes">  </span>The certification program requires 3
consecutive, successful practice sets that have at least 8 of 10 samples with
acceptable tracer recovery through RAS.<span style="mso-spacerun: yes"> 
</span>To maintain certification, a technician must produce 2 of 3 consecutive
sample sets with at least 8 of 10 samples with acceptable tracer recovery.<span
style="mso-spacerun: yes">  </span>Since implementation of the corrective
actions, re-runs for unacceptable tracer recovery for RAS are ~5%.<span
style="mso-spacerun: yes">  </span>Although RAS analysis has to be redone if
the tracer recovery is less than 40%, TIMS analysis may proceed if it is
greater than 15%.<span style="mso-spacerun: yes">  </span>The number of TIMS
samples lost through failure to meet this metric is &lt;1%.<span
style="mso-spacerun: yes">   </span><o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><u><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
font-family:"Times New Roman"'>Turn-around times<o:p></o:p></span></u></p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan;mso-outline-level:1'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>The Bioassay Program
has two categories for target turn-around-times for analysis and reporting results:
priority and routine. Samples designated for TIMS analysis are initially
analyzed by RAS to determine the plutonium-238 and -239 values, to screen for
elevated levels of plutonium, and to determine the tracer recovery.<span
style="mso-spacerun: yes">  </span>Urine samples designated for priority
plutonium analysis require RAS results to be reported within 8 working days and
TIMS results within 10 days.<span style="mso-spacerun: yes">  </span>Urine
samples designated for routine plutonium analysis require RAS results to be
reported within 25 working days and TIMS results within 35 days. Establishing
realistic target turn-around-times for sample analysis has required iterative
integration between the generators and the end-users of the data.<span
style="mso-spacerun: yes">  </span>The need for obtaining analytical data in a
timely fashion must be balanced with the historical routine performance of the
RAS and TIMS operations of sample receipt, login, preparation, analysis and
data reporting.<span style="mso-spacerun: yes">  </span><o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan;mso-outline-level:1'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Achievement of TIMS
turn-around times is totally dependent on the RAS portion of the program.<span
style="mso-spacerun: yes">  </span>In CY1998 TIMS met turn-around times 79%; in
1999 25%; and to date in 2000 90%.<span style="mso-spacerun: yes">   </span>The
work-suspension in late CY1998 created a significant backlog in RAS that
impacted TIMS turn-around times in CY1999 accordingly.<span
style="mso-spacerun: yes">  </span>In response to exposure accidents, sample
analyses have been completed through both RAS and TIMS in five days with
dedicated staff working 10-hour days solely on those samples. <i
style='mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan'><u><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
font-family:"Times New Roman"'>Throughput<o:p></o:p></span></u></p>

<p class=HTMLBody style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:widow-orphan;mso-outline-level:1;tab-stops:0in 481.5pt'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"'>Production
capability of the existing TIMS chemistry operation is 12 samples/week, which
is adequate to meet current in-house sample load.<span style="mso-spacerun:
yes">  </span>Increasing chemistry staff can easily accommodate additional
sample load. Analysis by TIMS with one instrument can handle up to 24
samples/week.<span style="mso-spacerun: yes">   </span>Samples analyzed in the
three years of operation have averaged about 300/year for routine turn-around,
and 20-50 for priority, well below capacity.<o:p></o:p></span></p>

<p class=HTMLBody style='margin-right:4.5pt;line-height:200%;mso-pagination:
widow-orphan;tab-stops:.25in 481.5pt'><span style='font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"'><span style='mso-tab-count:1'>      </span>The
TIMS facility houses three identical NBS 12-90 TIMS units, one of which is
dedicated to bioassay analyses.<span style="mso-spacerun: yes">  </span>The
DOELAP requires back-up capability, and the availability of the other two
instruments allows full back-up to support the Bioassay Program.<span
style="mso-spacerun: yes">  </span>Currently, a significant electronics upgrade
is being performed on all of the TIMS units.<span style="mso-spacerun: yes"> 
</span>Additionally, one unit is being modified and the necessary software
developed to fully automate the analysis of bioassay plutonium samples by
TIMS.<span style="mso-spacerun: yes">  </span>Full automation will allow the
technician to simply load the samples into the turret, and let the computer run
the analysis with no operator attention.<span style="mso-spacerun: yes"> 
</span>Automation will reduce labor costs for sample analysis by ~40%, and will
increase throughput efficiency by 50%.<span style="mso-spacerun: yes"> 
</span>Additionally, consistency between samples and background levels should
be improved by minimizing variation introduced by human operators.<span
style="mso-spacerun: yes">  </span>A second TIMS system will be automated in
the future to provide full back-up capability.<o:p></o:p></span></p>

<p class=WP9 style='margin-right:4.3pt;line-height:200%;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in'><u><span
style='font-style:normal'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></u></p>

<p class=WP9 style='margin-right:4.3pt;line-height:200%;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in'><u><span
style='font-style:normal'>Performance Evaluation (PE) Samples </span></u><!--[if supportFields]><u><span
style='font-style:normal'><span style='mso-element:field-begin'></span><span
style="mso-spacerun: yes"> </span>TC \l3 &quot;</span></u><![endif]--><!--[if supportFields]><u><span
style='font-style:normal'><span style='mso-element:field-end'></span></span></u><![endif]--><u><span
style='font-style:normal'><o:p></o:p></span></u></p>

<p class=BodyTextI1 style='margin-right:4.5pt;line-height:200%;mso-outline-level:
1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'>The
internal QA program requires the incorporation and analysis of QC samples
including blanks and single blind QC samples at a 5% level in the sample
batches.<span style="mso-spacerun: yes">  </span>These QC samples are
incorporated into the analysis batch during login and are processed
concurrently with the sample batch.<span style="mso-spacerun: yes"> 
</span>Duplicate samples are not analyzed due to volume limitations.<span
style="mso-spacerun: yes">  </span>The LANL Bioassay Program has established
operational control limits for acceptability of tracer recovery for RAS and
TIMS, <span style='font-size:10.0pt'>+/-</span> the Minimum Detectable Activity
(MDA) for the blank, and <span style='font-size:10.0pt'>+/-</span> 25% for the
bias on single-blind QC samples spiked at &gt;10X the MDA.<span
style="mso-spacerun: yes">  </span>The percent bias performance of
plutonium-239 blind QC samples, spiked at &gt; 10X MDA, and analyzed by TIMS from
September 1998 through February 2000 is shown in Figure 1.<span
style="mso-spacerun: yes">   </span></p>

<p class=BodyTextI1 style='margin-right:4.5pt;line-height:200%;mso-outline-level:
1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'>Early
data show a distinct positive bias, partially resulting from a slight body
burden of plutonium in the individual donating urine for preparation of the QC
samples, which was not observed at RAS analysis levels.<span
style="mso-spacerun: yes">   </span>This situation was remedied by establishing
a controlled system to identify urine donors, certify their urine as clean,
i.e., plutonium-free, through TIMS, and maintain an approved donor pool of
about 15 people.<span style="mso-spacerun: yes">  </span>The QC program
requires 5-10 liters of “certified” urine per week for use as RAS/TIMS blanks
and for the preparation of internal plutonium control samples.</p>

<p class=BodyTextIn style='margin-right:4.5pt;line-height:200%;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt'>Figure 2 compares the recent
RAS and TIMS plutonium-239 QC sample percent bias results that were outside the
acceptance criteria, along with the plutonium-242 tracer recoveries.<span
style="mso-spacerun: yes">  </span>All tracer recoveries are well above the
required TIMS 15%, and in the typical range for other samples that are within
control.<span style="mso-spacerun: yes">  </span>There appears to be no
correlation between tracer recoveries and percent bias.<span
style="mso-spacerun: yes">  </span>The percent bias between the RAS
plutonium-239 and TIMS plutonium-239 QC samples tracks very closely, which
indicates that there is no loss or contamination in the TIMS chemistry, or the
TIMS analysis.<span style="mso-spacerun: yes">  </span>Potential areas for
further process improvement include modifications in the preparation of QC
samples and RAS process chemistry.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;tab-stops:9.0pt .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt'><span style='mso-tab-count:
1'>   </span>The LANL Bioassay Program analytical chemistry laboratories
participate in the Oak Ridge National Laboratory (ORNL) In-vitro Bioassay
Inter-comparison Study (natural urine); the National Institute for Standards
and Technology (NIST) Radiochemistry Inter-comparison Program (synthetic
urine); and DOELAP (synthetic urine).<span style="mso-spacerun: yes"> 
</span>Currently, there is no program that is capable of providing routine PE
samples at the aCi level for evaluation of TIMS at 10-20X MDA.<span
style="mso-spacerun: yes">  </span>The ORNL program currently provides routine
PE samples at the lowest levels available at the fCi level, which is ~60X MDA
for plutonium-239 by TIMS. LANL plans to participate in a second
inter-comparison study designed to evaluate and validate the capabilities of
TIMS in the determination of ultra-low-levels of plutonium in synthetic urine
at the aCi level.<span style="mso-spacerun: yes">  </span>This study is being
coordinated by NIST and Duke Engineering and Services and is planned for CY
2000.<o:p></o:p></span></p>

<p class=BodyTextIn style='margin-right:4.5pt;line-height:200%;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt'>In CY1997, ORNL began
providing PE samples for the TIMS program. Results for plutonium-239 in urine
by TIMS have always met the –25% to +50% ANSI N13.30 [5] acceptance criteria
used by ORNL, as well as the more restrictive internal LANL values of +/-25%
relative bias are shown in Figure 3.<span style="mso-spacerun: yes">  
</span>There does not appear to be any correlation between the levels of spike
in the samples and the performance of TIMS, as the spike levels range from 9
fCi/Kg up to 1,500 fCi/Kg.<span style="mso-spacerun: yes">  </span>Each set
includes more than one spike level.<span style="mso-spacerun: yes">  </span>Precision
and bias seem to be more dependent over time with changes in the RAS processing
and changes in analysts.<span style="mso-spacerun: yes">  </span>The ORNL PE
samples have proven to be an invaluable tool in assessing the performance of
TIMS, and identifying areas of opportunity for improvement within the program.<a
name="_1015849729"></a><o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'>STATISTICAL DATA TREATMENT FOR TIMS<o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
layout-grid-mode:line'>Initially, data treatment used a running average of a
set of data points instead of considering each data point individually.<span
style="mso-spacerun: yes">  </span>In FY9<span style='color:black'>8,</span>
the software was modified to store each counting event and track it against
time and temperature, significantly changing the statistical approach to the
analysis of low-level TIMS data.<o:p></o:p></span></p>

<h1 style='margin-right:4.5pt'>Basic principles</h1>

<p class=MsoNormal style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
layout-grid-mode:line'>Count-rates for isotope masses of interest are measured
and the ratio of the isotope of interest to a known reference isotope is
determined.<span style="mso-spacerun: yes">  </span>Ratio determination is
complicated because the count rate is not constant, and the single ion counting
channel does not allow the isotope of interest and the reference isotope to be
measured concurrently.<span style="mso-spacerun: yes">  </span>Further
complications include background and isobar signal contributions that do not
originate from the isotopes of interest, and system noise that generates
occasional counts.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
layout-grid-mode:line'>Once noise, background, and isobar signal contributions
are subtracted from the data, curve shapes of the count rate, as a function of
time (and temperature) will be identical. </span><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt'>That is, <sub><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:69pt;
 height:17.25pt' o:ole="" fillcolor="window">
 <v:imagedata src="BAERCon-46p066i001.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=92 height=23
src="BAERCon-46p066i002.gif" v:shapes="_x0000_i1025"><![endif]></sub><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.2" ShapeID="_x0000_i1025"
  DrawAspect="Content" ObjectID="_1031645583">
 </o:OLEObject>
</xml><![endif]-->, where <sub><!--[if gte vml 1]><v:shape id="_x0000_i1026"
 type="#_x0000_t75" style='width:14.25pt;height:17.25pt' o:ole="" fillcolor="window">
 <v:imagedata src="BAERCon-46p066i003.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=19 height=23
src="BAERCon-46p066i004.gif" v:shapes="_x0000_i1026"><![endif]></sub><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.2" ShapeID="_x0000_i1026"
  DrawAspect="Content" ObjectID="_1031645584">
 </o:OLEObject>
</xml><![endif]--><span style="mso-spacerun: yes"> </span>is the count-rate for
isotope <i style='mso-bidi-font-style:normal'>i</i>, <sub><!--[if gte vml 1]><v:shape
 id="_x0000_i1027" type="#_x0000_t75" style='width:35.25pt;height:15.75pt'
 o:ole="" fillcolor="window">
 <v:imagedata src="BAERCon-46p066i005.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=47 height=21
src="BAERCon-46p066i006.gif" v:shapes="_x0000_i1027"><![endif]></sub><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.2" ShapeID="_x0000_i1027"
  DrawAspect="Content" ObjectID="_1031645585">
 </o:OLEObject>
</xml><![endif]-->is the count-rate for the reference isotope as a function of
time <i style='mso-bidi-font-style:normal'>t</i> and<i style='mso-bidi-font-style:
normal'> </i>temperature <i style='mso-bidi-font-style:normal'>T</i>, and <sub><!--[if gte vml 1]><v:shape
 id="_x0000_i1028" type="#_x0000_t75" style='width:12.75pt;height:17.25pt'
 o:ole="" fillcolor="window">
 <v:imagedata src="BAERCon-46p066i007.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=17 height=23
src="BAERCon-46p066i008.gif" v:shapes="_x0000_i1028"><![endif]></sub><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.2" ShapeID="_x0000_i1028"
  DrawAspect="Content" ObjectID="_1031645586">
 </o:OLEObject>
</xml><![endif]-->is the desired ratio between isotope <i style='mso-bidi-font-style:
normal'>i</i> and the reference isotope.</span><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:HELVETICA'><span style="mso-spacerun:
yes">   </span></span><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
layout-grid-mode:line'>Noise is removed based on Chauvenet's criterion.<span
style="mso-spacerun: yes">  </span>Background subtractions are made based on an
average of the half-mass measured on both sides of the peak of interest.<span
style="mso-spacerun: yes">  </span>The isobar is identified and removed by
taking advantage of the fact that the isobar count rate follows a different
curve than that of the reference isotope.<o:p></o:p></span></p>

<h1 style='margin-right:4.5pt'>Isobar correction</h1>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none;tab-stops:.25in'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt'><span
style='mso-tab-count:1'>      </span>The background corrected count-rate data for
the isotope <i style='mso-bidi-font-style:normal'>i</i> is fitted to a function
of the form <sub><!--[if gte vml 1]><v:shape id="_x0000_i1029" type="#_x0000_t75"
 style='width:87.75pt;height:36pt' o:ole="" fillcolor="window">
 <v:imagedata src="BAERCon-46p066i009.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=117 height=48
src="BAERCon-46p066i010.gif" v:shapes="_x0000_i1029"><![endif]></sub><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.2" ShapeID="_x0000_i1029"
  DrawAspect="Content" ObjectID="_1031645587">
 </o:OLEObject>
</xml><![endif]-->.<span style="mso-spacerun: yes">  </span>The desired isotope
ratio between the isotope <i style='mso-bidi-font-style:normal'>i</i> and the
reference isotope is given by <sub><!--[if gte vml 1]><v:shape id="_x0000_i1030"
 type="#_x0000_t75" style='width:14.25pt;height:17.25pt' o:ole="" fillcolor="window">
 <v:imagedata src="BAERCon-46p066i011.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=19 height=23
src="BAERCon-46p066i012.gif" v:shapes="_x0000_i1030"><![endif]></sub><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.2" ShapeID="_x0000_i1030"
  DrawAspect="Content" ObjectID="_1031645588">
 </o:OLEObject>
</xml><![endif]-->.<span style="mso-spacerun: yes">  </span>The count-rate
function for isotope <i style='mso-bidi-font-style:normal'>i</i> is given by <sub><!--[if gte vml 1]><v:shape
 id="_x0000_i1031" type="#_x0000_t75" style='width:1in;height:17.25pt' o:ole=""
 fillcolor="window">
 <v:imagedata src="BAERCon-46p066i013.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=96 height=23
src="BAERCon-46p066i014.gif" v:shapes="_x0000_i1031"><![endif]></sub><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.2" ShapeID="_x0000_i1031"
  DrawAspect="Content" ObjectID="_1031645589">
 </o:OLEObject>
</xml><![endif]-->, which corresponds to the desired condition noted earlier
stating that the isotope and reference have the same time-temperature function
shaped curves.<span style="mso-spacerun: yes">  </span>The count rate curve for
the isobar is given by <sub><!--[if gte vml 1]><v:shape id="_x0000_i1032"
 type="#_x0000_t75" style='width:104.25pt;height:36pt' o:ole="" fillcolor="window">
 <v:imagedata src="BAERCon-46p066i015.wmz" o:title=""/>
</v:shape><![endif]--><![if !vml]><img width=139 height=48
src="BAERCon-46p066i016.gif" v:shapes="_x0000_i1032"><![endif]></sub><!--[if gte mso 9]><xml>
 <o:OLEObject Type="Embed" ProgID="Equation.2" ShapeID="_x0000_i1032"
  DrawAspect="Content" ObjectID="_1031645591">
 </o:OLEObject>
</xml><![endif]-->, such that the isobar decays to zero at infinite time.<span
style='layout-grid-mode:line'><span style="mso-spacerun: yes">  </span>This
model generally describes the data quite well.<span style="mso-spacerun: yes"> 
</span>Figure 4 shows the background, isobar, and isotope counts components. <o:p></o:p></span></span></p>

<h1 style='margin-right:4.5pt'>Further work</h1>

<p class=BodyTextI1 style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><span style='layout-grid-mode:line'>The present method of data reduction
is only applicable to data where the background and isobar contributions are
small relative to the uncertainty in the count-rate of the reference
isotope.<span style="mso-spacerun: yes">  </span>This limitation is being
addressed in an ongoing effort by applying the background and isobar model to
the reference data and by fitting all the data simultaneously.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
layout-grid-mode:line'>The functional form of the isobar model is also being
refined.<span style="mso-spacerun: yes">  </span>There is evidence that there
is a component of the isobar that is not proportional to the reference curve,
which is not presently accounted for.<span style="mso-spacerun: yes"> 
</span>Much of the blank appears to be a residual isobar that cannot be
subtracted at the present time, but could likely be reduced with an improved
isobar model.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><u><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'>Minimum detectable activity<o:p></o:p></span></u></p>

<p class=MsoNormal style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
layout-grid-mode:line'>Chemical yield appears to be the most important factor
in determining MDAs.<span style="mso-spacerun: yes">  </span>Since the MDA is
based on the variability of blank data, low chemical yield</span><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol;
layout-grid-mode:line;mso-char-type:symbol;mso-symbol-font-family:Symbol'><span
style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>¾</span></span><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'>which
results in low count rates</span><span style='font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:Symbol;layout-grid-mode:line;mso-char-type:symbol;
mso-symbol-font-family:Symbol'><span style='mso-char-type:symbol;mso-symbol-font-family:
Symbol'>¾</span></span><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
layout-grid-mode:line'>leads to higher MDAs due to lower precision and more
variable blank measurements.<span style="mso-spacerun: yes">   </span>Figure 5
shows plutonium-239 process blanks as a function of date and matrix. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
layout-grid-mode:line'>For the first year water blanks were used.<span
style="mso-spacerun: yes">  </span>For the past year both water and urine
blanks were used, and currently all blanks are TIMS certified, clean
urine.<span style="mso-spacerun: yes">  </span>Urine blanks yield significantly
lower blanks, apparently due to better chemical yield. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<h2 style='margin-left:0in'>LESSONS LEARNED </h2>

<h1 style='margin-right:4.5pt'>Sophisticated process chemistry</h1>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'><span style="mso-spacerun: yes">        </span>Although only a fraction
of the urine samples analyzed for plutonium eventually go through TIMS, it is
essential that the chemistry used is sufficiently clean to meet the sensitivity
requirements for TIMS, such that any sample analyzed by RAS can be further
processed for TIMS if required.<span style="mso-spacerun: yes">  </span>The
chemistry used must be sufficiently robust and efficient to be applied to
~2,000 samples a year for alpha-spectroscopy, of which 300-400 go on for TIMS
analysis.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;text-indent:27.0pt;line-height:
200%;mso-pagination:none;tab-stops:9.0pt'><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;layout-grid-mode:line'>Techniques commonly used for
RAS analysis were not suitable for the more sensitive TIMS analysis.<span
style="mso-spacerun: yes">  </span>Practices that are perfectly acceptable for
RAS can cause detectable sample contamination when used to process TIMS
samples. All operating procedures had to be re-evaluated to ensure
compatibility with the more sensitive measurement technique.<span
style="mso-spacerun: yes">  </span>Processing of samples has to be conducted in
Class-100 clean-rooms to support the sensitivity of TIMS.<span
style="mso-spacerun: yes">  </span>Although conducted in a clean-room facility,
the rooms, equipment and reagents used by the bioassay program have to be
&quot;blanked&quot; prior to use, to ensure that there are no programs in the
area that could negatively affect the bioassay results.<o:p></o:p></span></p>

<h1 style='margin-right:4.5pt'>Culture change</h1>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'><span style='mso-tab-count:1'>            </span>Transition to a routine
production environment required implementation of a much more rigorous
formality of operations than was originally used during the research and
development phase of the TIMS program.<span style="mso-spacerun: yes"> 
</span>It took two years of operation to fully develop operating procedures and
protocols acceptable to the chemists, TIMS analysts, and QA staff.<span
style="mso-spacerun: yes">  </span>Once the analytical procedures were in
place, a significant culture change was required to accept and implement the
rigor and consistency imposed by the QA program. <o:p></o:p></span></p>

<h1 style='margin-right:4.5pt'>Attention to detail</h1>

<p class=MsoBlockText style='margin-left:0in;tab-stops:.25in'>The RAS chemistry
developed for TIMS is much more sensitive to analyst technique and attention to
detail.<span style="mso-spacerun: yes">  </span>A tracking system was developed
to monitor the performance of analysts.<span style="mso-spacerun: yes"> 
</span>As the formality of operations has increased, the program has become
more rigorous and demanding, and while personnel turnover is minimal, periodic
re-training and process refreshers are essential to maintain proficiency.<span
style="mso-spacerun: yes">  </span></p>

<h1 style='margin-right:4.5pt'>Equipment</h1>

<p class=MsoNormal style='margin-right:4.5pt;text-indent:.5in;line-height:200%;
mso-pagination:none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;
layout-grid-mode:line'>Most equipment is used only once to minimize the
potential for cross-contamination.<span style="mso-spacerun: yes"> 
</span>However, some equipment is simply too expensive to be single-use, e.g.
the 2 liter Teflon</span><sup><span style='layout-grid-mode:line'>®</span></sup><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'>
bottles that are used to precipitate the plutonium from urine.<span
style="mso-spacerun: yes">   </span>Early on, the bottles were carefully
cleaned and re-used at random.<span style="mso-spacerun: yes">  </span>The
processing of high-level QC samples (some over 10,000 times above TIMS limits
of detection) resulted in contamination of samples at levels above the TIMS
limits of detection and may have caused false positive results to be reported
during the first year TIMS analyses were performed.<span style="mso-spacerun:
yes">  </span>This contamination was not identified until sufficient TIMS data
were available. To solve the contamination problem, levels of plutonium in the
QC samples were reduced, and a strict protocol for Teflon</span><sup><span
style='layout-grid-mode:line'>®</span></sup><span style='font-size:12.0pt;
mso-bidi-font-size:10.0pt;layout-grid-mode:line'> bottle re-use was
implemented.<span style="mso-spacerun: yes">   </span>The containers used for
QC samples are segregated and re-used only for other QC samples, and not used
for customer samples.<span style="mso-spacerun: yes">  </span>Additionally, the
Teflon</span><sup><span style='layout-grid-mode:line'>®</span></sup><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'>
bottles are not re-used in incident response situations where elevated-levels
of plutonium in urine are suspected.<o:p></o:p></span></p>

<h1 style='margin-right:4.5pt'>Throughput<span style="mso-spacerun: yes"> 
</span></h1>

<p class=MsoBlockText style='margin-left:0in'>A culture change was also
required to move from success on one set of samples to success for every set of
samples on a continuing daily basis.<span style="mso-spacerun: yes"> 
</span>The primary reason for sample loss is tracer recovery<span
style='font-family:Symbol;mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:
"Times New Roman";mso-char-type:symbol;mso-symbol-font-family:Symbol'><span
style='mso-char-type:symbol;mso-symbol-font-family:Symbol'>¾</span></span>generally
a result of error in technique, inattention to detail, and occasionally matrix
problems. Physical sample losses, e.g., spilling, dropping, mix-ups, etc., are
rare.</p>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'><span style="mso-spacerun: yes">           </span>Samples from the
routine program are rigorously scheduled, with negotiated sample loads and
turn-around times.<span style="mso-spacerun: yes">  </span>In incident response
situations, an additional sample load of priority samples with faster
turn-around times severely impacts the routine program.<span
style="mso-spacerun: yes">  </span>Parallel systems were developed to provide
sufficient resources to maintain the routine program, while meeting deadlines
for priority samples.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;line-height:200%;mso-pagination:
none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'>CONCLUSIONS <o:p></o:p></span></p>

<p class=MsoBlockText style='margin-left:0in'>Transition of an in-house
research tool to a production analytical process has provided a fertile area
for application of formality of operations and project management
practices.<span style="mso-spacerun: yes">  </span>Continuous improvements in
efficiency and the quality of product include: increasing the plutonium ionization
efficiency to increase sensitivity and lower blanks; improving the stability of
the TIMS instruments through electronics upgrades and automation: developing
more sophisticated data reduction and background correction routines; and
maintaining a rigorous QC program to monitor ongoing TIMS analytical quality.</p>

<p class=MsoNormal style='margin-right:4.5pt;mso-pagination:none'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;mso-pagination:none'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;mso-pagination:none'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'>REFERENCES<o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;mso-pagination:none'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;mso-pagination:none'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'>1.<span
style="mso-spacerun: yes">  </span>United States of America, Code of Federal
Regulations, 10 CFR 835.402(b).<o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;mso-pagination:none'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:4.5pt;margin-bottom:0in;
margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;mso-pagination:none;
mso-list:l0 level1 lfo7;tab-stops:list 0in'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><![endif]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'>W.C.
Inkret, et al, <u>International Journal of Mass Spectrometry,</u> 178 (1998)
113-120.<i style='mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=MsoNormal style='margin-right:4.5pt;mso-pagination:none'><i
style='mso-bidi-font-style:normal'><span style='font-size:12.0pt;mso-bidi-font-size:
10.0pt;layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></i></p>

<p class=MsoBodyTextIndent style='margin-left:.25in'>3.<span style='mso-tab-count:
1'>   </span> Los Alamos National Laboratory Analytical Bioassay Project
Management Plan, LA-UR-99-4817, February 2000.</p>

<p class=WP9 style='margin-right:4.5pt'><span style='layout-grid-mode:line;
font-style:normal'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=WP9 style='margin-top:0in;margin-right:4.5pt;margin-bottom:0in;
margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;mso-list:l1 level1 lfo3;
tab-stops:list 0in'><![if !supportLists]><span style='layout-grid-mode:line;
font-style:normal'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><![endif]><span style='layout-grid-mode:line;font-style:normal'>The
U.S. Department of Energy Laboratory Accreditation Program for Radiobioassay,
DOE-STD-1112-98, December 1998.<span style="mso-spacerun: yes">  </span><o:p></o:p></span></p>

<p class=WP9 style='margin-right:4.5pt'><span style='layout-grid-mode:line;
font-style:normal'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:4.5pt;margin-bottom:0in;
margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;mso-pagination:none;
mso-list:l1 level1 lfo3;tab-stops:list 0in'><![if !supportLists]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'>5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><![endif]><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:line'>American
National Standard, Health Physics Society, Performance Criteria for <o:p></o:p></span></p>

<p class=MsoNormal style='margin-right:4.5pt;text-indent:.25in;mso-pagination:
none'><span style='font-size:12.0pt;mso-bidi-font-size:10.0pt;layout-grid-mode:
line'>Radiobioassay, HPS N13.30-1996.<span style='mso-tab-count:1'>           </span><o:p></o:p></span></p>

<p class=BodyTextIn style='margin-right:4.5pt;text-indent:0in;line-height:200%;
tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in'><!--[if gte vml 1]><o:wrapblock><v:shape
  id="_x0000_s1057" type="#_x0000_t75" style='position:absolute;margin-left:-61.2pt;
  margin-top:0;width:7in;height:129.6pt;z-index:5;
  mso-position-horizontal-relative:text;mso-position-vertical-relative:text'
  o:allowincell="f" fillcolor="#0c9">
  <v:imagedata src="BAERCon-46p066i017.wmz" o:title=""/>
  <v:textbox style='mso-next-textbox:#_x0000_s1057'/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![if gte mso 9]><o:OLEObject Type="Embed" ProgID="Excel.Sheet.8"
  ShapeID="_x0000_s1057" DrawAspect="Content" ObjectID="_1031645592">
 </o:OLEObject>
 <![endif]><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:
 relative;z-index:0;left:-82px;top:0px;width:672px;height:173px'><img
 width=672 height=173 src="BAERCon-46p066i018.gif" v:shapes="_x0000_s1057"></span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:12.0pt;mso-bidi-font-size:10.0pt'>FIGURES<o:p></o:p></span></p>

<p class=BodyTextIn style='margin-right:4.5pt;text-indent:0in;line-height:normal;
tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<br style='mso-ignore:vglayout' clear=ALL>

<p class=BodyTextIn style='margin-right:4.5pt;text-indent:0in;line-height:normal;
tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in'><!--[if gte vml 1]><o:wrapblock><v:shape
  id="_x0000_s1053" type="#_x0000_t75" style='position:absolute;margin-left:-32.4pt;
  margin-top:0;width:468pt;height:165.6pt;z-index:3;
  mso-position-horizontal-relative:text;mso-position-vertical-relative:text'
  o:allowincell="f">
  <v:imagedata src="BAERCon-46p066i019.wmz" o:title=""/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![if gte mso 9]><o:OLEObject Type="Embed" ProgID="Excel.Sheet.8"
  ShapeID="_x0000_s1053" DrawAspect="Content" ObjectID="_1031645593">
 </o:OLEObject>
 <![endif]><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:
 relative;z-index:1;left:-43px;top:0px;width:624px;height:221px'><img
 width=624 height=221 src="BAERCon-46p066i020.gif" v:shapes="_x0000_s1053"></span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='font-size:12.0pt;mso-bidi-font-size:10.0pt'>Figure 1: Results of
Pu-239 TIMS Blind QC samples spiked at &gt;10X MDA, September 1998 through
February 20000.<o:p></o:p></span></p>

<p class=BodyTextIn style='margin-right:4.5pt;text-indent:0in;line-height:normal;
tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 5.5in 6.0in 6.5in'><span
style='font-size:12.0pt;mso-bidi-font-size:10.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<br style='mso-ignore:vglayout' clear=ALL>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'>Figure
2: RAS and TIMS Pu-239 QC results that exceed +/- 25% relative bias, September
1999 through February 2000.</p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><!--[if gte vml 1]><o:wrapblock><v:shape
  id="_x0000_s1056" type="#_x0000_t75" style='position:absolute;margin-left:-3.6pt;
  margin-top:0;width:365.4pt;height:148.2pt;z-index:4;
  mso-position-horizontal-relative:text;mso-position-vertical-relative:text'
  o:allowincell="f" fillcolor="#0c9">
  <v:imagedata src="BAERCon-46p066i021.wmz" o:title=""/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![if gte mso 9]><o:OLEObject Type="Embed" ProgID="Excel.Sheet.8"
  ShapeID="_x0000_s1056" DrawAspect="Content" ObjectID="_1031645594">
 </o:OLEObject>
 <![endif]><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:
 relative;z-index:2;left:-5px;top:0px;width:487px;height:198px'><img width=487
 height=198 src="BAERCon-46p066i022.gif" v:shapes="_x0000_s1056"></span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<br style='mso-ignore:vglayout' clear=ALL>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'>Figure
3: TIMS analysis of ORNL PE samples spiked with Pu-239, January 1997 through
December 1999.</p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><!--[if gte vml 1]><o:wrapblock><v:shape
  id="_x0000_s1046" type="#_x0000_t75" style='position:absolute;margin-left:-10.8pt;
  margin-top:0;width:428.4pt;height:173.5pt;z-index:1;
  mso-position-horizontal-relative:text;mso-position-vertical-relative:text'
  o:allowincell="f">
  <v:imagedata src="BAERCon-46p066i023.wmz" o:title="16428"/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:
 relative;z-index:3;left:-14px;top:0px;width:571px;height:231px'><img
 width=571 height=231 src="BAERCon-46p066i024.gif" v:shapes="_x0000_s1046"></span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<br style='mso-ignore:vglayout' clear=ALL>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'>Figure
4: Components of the fit to the 239-plutonium counts.</p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:-.25in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><span
style='layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:-.25in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><!--[if gte vml 1]><o:wrapblock><v:shape
  id="_x0000_s1049" type="#_x0000_t75" style='position:absolute;margin-left:32.4pt;
  margin-top:0;width:309.6pt;height:224.65pt;z-index:2;
  mso-position-horizontal-relative:text;mso-position-vertical-relative:text'
  o:allowincell="f" fillcolor="#60f">
  <v:imagedata src="BAERCon-46p066i025.wmz" o:title=""/>
  <v:shadow color="#b2b2b2"/>
  <v:textbox inset="7.25pt,46038emu,7.25pt,46038emu"/>
  <w:wrap type="topAndBottom"/>
 </v:shape><![if gte mso 9]><o:OLEObject Type="Embed" ProgID="Excel.Sheet.8"
  ShapeID="_x0000_s1049" DrawAspect="Content" ObjectID="_1031645596">
 </o:OLEObject>
 <![endif]><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0 align=left>
  <tr>
   <td width=43 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=413 height=300 src="BAERCon-46p066i026.gif" v:shapes="_x0000_s1049"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:-.25in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><span
style='layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:-.25in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><span
style='layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:-.25in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><span
style='layout-grid-mode:line'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>

<br style='mso-ignore:vglayout' clear=ALL>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:-.25in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><span
style='layout-grid-mode:line'>Figure 5: Plutonium-239 process blanks as a
function of date and sample matrix</span></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=BodyTextI1 style='text-indent:0in;mso-outline-level:1;tab-stops:0in .5in 1.0in 1.5in 2.0in 2.5in 3.0in 3.5in 4.0in 4.5in 5.0in 441.0pt 459.0pt 6.5in'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
